General Information:
Id: | 4,719 |
Diseases: |
Neurological
|
Mammalia | |
review | |
Reference: | Mao LM et al.(2011) Post-translational modification biology of glutamate receptors and drug addiction Front Neuroanat 5: 19 [PMID: 21441996] |
Interaction Information:
Comment | Group I metabotropic glutamate receptors (mGluR1/5 subtypes) are positively coupled to phospholipase Cbeta1 through Galphaq proteins (GNAQ). |
Formal Description Interaction-ID: 46758 |
|
Drugbank entries | Show/Hide entries for GRM1 |
Comment | The GluA1 C-terminus has four identified phosphorylation sites at serine 818 (S818), S831, threonine 840 (T840), and S845. Acute phosphorylation of GluA1 S818 by PKC promoted GluA1 synaptic incorporation and an activity-dependent form of synaptic plasticity, long-term potentiation. |
Formal Description Interaction-ID: 46763 |
gene/protein Protein kinase C increases_phosphorylation of gene/protein |
Drugbank entries | Show/Hide entries for GRIA1 |
Comment | Group I metabotropic glutamate receptors (mGluR1/5 subtypes) are positively coupled to phospholipase Cbeta1 through Galphaq proteins (GNAQ). |
Formal Description Interaction-ID: 46772 |
|
Comment | Acute phosphorylation of GluA1 Ser818 by PKC promoted GluA1 synaptic incorporation and an activity-dependent form of synaptic plasticity, long-term potentiation. PKC/CaMKII- (Ca2+/calmodulin-dependent protein kinase II) -sensitive GluA1-Ser831 and PKA-sensitive Ser845 phosphorylation potentiated AMPAR currents and augmented also LTP. GluA1-Ser845/Ser831 phosphorylation is likely to be upregulated to increase surface AMPAR expression and thereby enhance AMPAR transmission related to behavioral plasticity. |
Formal Description Interaction-ID: 46773 |
protein modification GRIA1-phos increases_activity of process |
Comment | Acute phosphorylation of GluA1 S818 by PKC promoted GluA1 synaptic incorporation and an activity-dependent form of synaptic plasticity, long-term potentiation. |
Formal Description Interaction-ID: 46774 |
|
Comment | The GluA1 C-terminus has four identified phosphorylation sites at serine 818 (S818), S831, threonine 840 (T840), and S845. PKC/CaMKII- (Ca2+/calmodulin-dependent protein kinase II) -sensitive S831 and PKA-sensitive S845 phosphorylation potentiated AMPAR currents and augmented LTP. |
Formal Description Interaction-ID: 46776 |
gene/protein CAMK2 increases_phosphorylation of gene/protein |
Drugbank entries | Show/Hide entries for GRIA1 |
Comment | The GluA1 C-terminus has four identified phosphorylation sites at serine 818 (S818), S831, threonine 840 (T840), and S845. PKC/CaMKII- (Ca2+/calmodulin-dependent protein kinase II) -sensitive S831 and PKA-sensitive S845 phosphorylation potentiated AMPAR currents and augmented LTP. GluA1-Ser845/Ser831 phosphorylation is likely to be upregulated to increase surface AMPAR expression and thereby enhance AMPAR transmission related to behavioral plasticity. |
Formal Description Interaction-ID: 46781 |
complex/PPI Protein kinase A increases_phosphorylation of gene/protein |
Drugbank entries | Show/Hide entries for GRIA1 |
Comment | The GluA1 C-terminus has four identified phosphorylation sites at serine 818 (S818), S831, threonine 840 (T840), and S845. T840 is dephosphorylated by NMDAR signals, which is implicated in long-term depression. |
Formal Description Interaction-ID: 46795 |
|
Comment | GRIA1 is part of the AMPA receptor complex. |
Formal Description Interaction-ID: 46796 |
|
Drugbank entries | Show/Hide entries for GRIA1 |
Comment | Dopamine is a strong regulator of the site-specific phosphorylation of striatal GluA1 subunits. By stimulating D1 dopamine receptors and associated cAMP/ PKA pathways, the D1 agonist and psychostimulants (cocaine and amphetamine) increased GluA1 phosphorylation preferentially at Ser845 in striatal neurons. |
Formal Description Interaction-ID: 46806 |
|
Drugbank entries | Show/Hide entries for Dopamine or GRIA1 |
Comment | Dopamine is a strong regulator of the site-specific phosphorylation of striatal GluA1 subunits. By stimulating D1 dopamine receptors and associated cAMP/ PKA pathways, the D1 agonist and psychostimulants (cocaine and amphetamine) increased GluA1 phosphorylation preferentially at Ser845 in striatal neurons. |
Formal Description Interaction-ID: 46816 |
drug/chemical compound increases_phosphorylation of gene/protein |
Drugbank entries | Show/Hide entries for GRIA1 |
Comment | The dopamine D2 receptor inhibits GluA1- Ser845 phosphorylation. |
Formal Description Interaction-ID: 46873 |
|
Drugbank entries | Show/Hide entries for DRD2 or GRIA1 |
Comment | Cocaine-sensitized or heroin self-administering rodents were associated with increased phosphorylation at GluA1-Ser845 in the NAc (nucleus accumbens) and at Ser831 in the CPu (caudate-putamen). Increased accumbens shell GluA1-Ser831 phosphorylation was seen in animals showing reinstatement of cocaine-seeking. |
Formal Description Interaction-ID: 46874 |
|
Drugbank entries | Show/Hide entries for Cocaine or GRIA1 |
Comment | In addition to GluA1, elevated GluA2-Ser880 phosphorylation in the NAc was related to reinstatement of cocaine-seeking. |
Formal Description Interaction-ID: 46876 |
|
Drugbank entries | Show/Hide entries for Cocaine or GRIA2 |
Comment | Cocaine-sensitized or heroin self-administering rodents were associated with increased phosphorylation at GluA1-Ser845 in the NAc (nucleus accumbens) and at Ser831 in the CPu (caudate-putamen). |
Formal Description Interaction-ID: 46934 |
drug/chemical compound increases_phosphorylation of gene/protein |
Drugbank entries | Show/Hide entries for GRIA1 |
Comment | GRIA1-T840 is not a substrate of the common kinases such as PKA, PKC, or CaMKII, but it appears to be a substrate of p70S6 kinase. T840 is dephosphorylated by NMDAR signals, which is implicated in long-term depression. |
Formal Description Interaction-ID: 46982 |
|
Drugbank entries | Show/Hide entries for GRIA1 |
Comment | Group I metabotropic glutamate receptors (mGluR1/5 subtypes) are positively coupled to phospholipase Cbeta1 through Galphaq proteins (GNAQ). |
Formal Description Interaction-ID: 49373 |
|
Drugbank entries | Show/Hide entries for GRM5 |